These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6594241)

  • 21. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
    Revesz D; Chelghoum Y; Le QH; Elhamri M; Michallet M; Thomas X
    Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic high-dose ara-C for the treatment of meningeal leukemia in adult acute lymphoblastic leukemia and non-Hodgkin's lymphoma.
    Morra E; Lazzarino M; Inverardi D; Brusamolino E; Orlandi E; Canevari A; Pagnucco G; Bernasconi C
    J Clin Oncol; 1986 Aug; 4(8):1207-11. PubMed ID: 3461134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mitoxantrone and conventional-dose cytosine arabinoside for relapsed and refractory acute leukemia].
    Wakita A; Murase T; Uchida T; Fujiwara Y; Tanaka M; Ohkita T
    Gan To Kagaku Ryoho; 1992 May; 19(5):653-7. PubMed ID: 1580638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DV-ICE, intensive induction and early transplantation for adult patients with acute lymphoblastic leukemia: a phase II study.
    Dudler C; Bargetzi M; Tichelli A; Gratwohl A; Passweg JR; Wernli M
    Eur J Haematol; 2009 Dec; 83(6):512-8. PubMed ID: 19614953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mitoxantrone and standard dose cytosine arabinoside therapy in refractory or relapsed acute leukemia.
    Keskin A; Tombuloğlu M; Atamer MA; Büyükkeçeci F
    Acta Haematol; 1994; 92(1):14-7. PubMed ID: 7985476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fludarabine and cytarabine as a sequential infusion regimen for treatment of adults with recurrent, refractory or poor prognosis acute leukemia.
    Vidarsson B; Abonour R; Williams EC; Woodson RD; Turman NJ; Kim K; Mosher DF; Wiersma SR; Longo WL
    Leuk Lymphoma; 2001 Apr; 41(3-4):321-31. PubMed ID: 11378544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Granulocyte colony-stimulating factor following chemotherapy in elderly patients with newly diagnosed acute myelogenous leukemia.
    Maslak PG; Weiss MA; Berman E; Yao TJ; Tyson D; Golde DW; Scheinberg DA
    Leukemia; 1996 Jan; 10(1):32-9. PubMed ID: 8558934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-dose cytosine arabinoside, daunomycin and 6-thioguanine in relapsed or refractory acute nonlymphocytic leukemia.
    Garewal H; Durie BG; Greenberg B
    Oncology; 1987; 44(6):333-5. PubMed ID: 3684173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Combination of AMSA-high dose cytosine arabinoside in acute leukemia].
    Zittoun R; Rio B; Marie JP; Blanc CM
    Presse Med; 1985 Jun; 14(26):1417-20. PubMed ID: 3161047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia.
    Hofmann WK; Heil G; Zander C; Wiebe S; Ottmann OG; Bergmann L; Hoeffken K; Fischer JT; Knuth A; Kolbe K; Schmoll HJ; Langer W; Westerhausen M; Koelbel CB; Hoelzer D; Ganser A
    Ann Hematol; 2004 Aug; 83(8):498-503. PubMed ID: 15156346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Idarubicin/cytosine arabinoside and mitoxantrone/etoposide for the treatment of de novo acute myelogenous leukemia.
    Haas R; Ho AD; Del Valle F; Fischer JT; Ehrhardt R; Döhner H; Witt B; Huberts H; Kaplan E; Hunstein W
    Semin Oncol; 1993 Dec; 20(6 Suppl 8):20-6. PubMed ID: 8290968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clofarabine in combination with a standard remission induction regimen (cytosine arabinoside and idarubicin) in patients with previously untreated intermediate and bad-risk acute myelogenous leukemia (AML) or high-risk myelodysplastic syndrome (HR-MDS): phase I results of an ongoing phase I/II study of the leukemia groups of EORTC and GIMEMA (EORTC GIMEMA 06061/AML-14A trial).
    Willemze R; Suciu S; Muus P; Halkes CJ; Meloni G; Meert L; Karrasch M; Rapion J; Vignetti M; Amadori S; de Witte T; Marie JP
    Ann Hematol; 2014 Jun; 93(6):965-75. PubMed ID: 24682421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Teniposide (VM-26) and continuous infusion cytosine arabinoside for initial induction failure in childhood acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study.
    Ochs J; Rivera GK; Pollock BH; Buchanan G; Crist W; Freeman AI
    Cancer; 1990 Oct; 66(8):1671-7. PubMed ID: 2208021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CECA-cyclophosphamide, etoposide, carboplatin and cytosine arabinoside--a new salvage regimen for relapsed or refractory acute myelogenous leukemia.
    Kornblau SM; Kantarjian H; O'Brien S; Andreeff M; Koller CA; Beran M; Keating M; Estey E
    Leuk Lymphoma; 1998 Jan; 28(3-4):371-5. PubMed ID: 9517508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction therapy for acute myelogenous leukemia in patients over 60 years with intermediate-dose cytosine arabinoside, mitoxantrone and etoposide.
    Shepherd JD; Reece DE; Barnett MJ; Klingemann HG; Nantel SH; Sutherland HJ; Phillips GL
    Leuk Lymphoma; 1993 Feb; 9(3):211-5. PubMed ID: 8471979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of refractory acute myeloid leukemia with mAMSA and VP 16-213 in combination: results of a clinical phase I/II study.
    Hiddemann W; Urbanitz D; Preusser P; Achterrath W; Büchner T
    Hematol Oncol; 1989; 7(4):267-73. PubMed ID: 2737607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-dose cytosine arabinoside and mitoxantrone (HAM) for the treatment of refractory acute lymphoblastic leukemia.
    Hiddemann W; Kreutzmann H; Donhuijsen-Ant R; Planker M; Wendt FC; Büchner T
    Onkologie; 1987 Feb; 10(1):11-2. PubMed ID: 3295619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of childhood acute lymphoblastic leukemia with intermediate-dose cytosine arabinoside and adriamycin.
    Ishii E; Hara T; Ohkubo K; Matsuzaki A; Takeuchi T; Ueda K
    Med Pediatr Oncol; 1986; 14(2):73-7. PubMed ID: 3458999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [VP 16-213 in the treatment of acute leukemia in childhood].
    Esumi N; Arakawa S; Imashuku S
    Gan To Kagaku Ryoho; 1983 Mar; 10(3):848-51. PubMed ID: 6576730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of chronic lymphocytic leukemia using chlorambucil and prednisone with or without cycle-active consolidation chemotherapy. A Southeastern Cancer Study Group Trial.
    Keller JW; Knospe WH; Raney M; Huguley CM; Johnson L; Bartolucci AA; Omura GA
    Cancer; 1986 Sep; 58(6):1185-92. PubMed ID: 3527402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.